Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 78
Titolo Tipologia Data di pubblicazione Autori File
Long-term course of oxaliplatin-induced polyneuropathy: a prospective two-year follow-up study 01 - Articolo su rivista 2014 ALBERTI, PAOLACORTINOVIS, DIEGO LUIGICAZZANIGA, MARINA ELENACAVALETTI, GUIDO ANGELO +
Efficacy and Safety of the All-Oral Schedule of Metronomic Vinorelbine and Capecitabine in Locally Advanced or Metastatic Breast Cancer Patients: The Phase I-II VICTOR-1 Study 01 - Articolo su rivista 2014 Cazzaniga MEBidoli P +
Pharmacogenetic interaction analysis of VEGFR-2 and IL-8 polymorphisms in advanced breast cancer patients treated with paclitaxel and bevacizumab 01 - Articolo su rivista 2014 Cazzaniga M +
Everolimus-based therapy in patients with hormone receptor-positive, HER2- advanced breast cancer: Management considerations 01 - Articolo su rivista 2015 Cazzaniga M +
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study 01 - Articolo su rivista 2015 Cazzaniga M +
"Why my parent is ill?" A specific, multidisciplinary intervention to enhance comunication to cancer patients' children 02 - Intervento a convegno 2015 Cazzaniga, MEBani, MRIVA, FRANCESCATagliabue, LBidoli, PMazza, U +
Genetic determinants of chronic oxaliplatin-induced peripheral neurotoxicity: A genome-wide study replication and meta-analysis 01 - Articolo su rivista 2015 ALBERTI, PAOLACORTINOVIS, DIEGO LUIGICAZZANIGA, MARINA ELENACAVALETTI, GUIDO ANGELO +
Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study 01 - Articolo su rivista 2016 M. Cazzaniga +
Metronomic oral vinorelbine in advanced breast cancer and non-small-cell lung cancer: Current status and future development 01 - Articolo su rivista 2016 Cazzaniga M +
A Multidisciplinary Intervention to Tell Children about the Parent's Cancer: Preliminary Results 02 - Intervento a convegno 2016 Ripamonti, CCazzaniga, MBani, MMazza, U +
Demographic, tumor and clinical features of clinical trials versus clinical practice patients with HER2-positive early breast cancer: results of a prospective study 01 - Articolo su rivista 2016 Cazzaniga M +
Fulvestrant (FUL) as first-line therapy in HR+ve, HER2-ve advanced breast cancer (ABC) patients (pts): when clinical practice comes earlier than clinical trials. Results from the GIM-13 AMBRA study 02 - Intervento a convegno 2017 Cazzaniga M. +
Metronomic chemotherapy for advanced breast cancer patients 01 - Articolo su rivista 2017 Cazzaniga M +
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study 01 - Articolo su rivista 2017 Cazzaniga M +
In reply to Kadri Altundag 01 - Articolo su rivista 2017 Cazzaniga, M
Dose intensity and efficacy of the combination of everolimus and exemestane (EVE/EXE) in a real-world population of hormone receptor-positive (ER+/PgR+), HER2-negative advanced breast cancer (ABC) patients: a multicenter Italian experience 01 - Articolo su rivista 2017 Cazzaniga M +
Everolimus plus exemestane in advanced breast cancer: Safety results of the BALLET study on patients previously treatedwithout and with chemotherapy in the metastatic setting 01 - Articolo su rivista 2017 Cazzaniga M +
Metronomic Chemotherapy in Triple-Negative Metastatic Breast Cancer: The Future Is Now? 01 - Articolo su rivista 2017 Cazzaniga M. E. +
Nab-Paclitaxel in Advanced HER2-negative Breast Cancer Patients: Efficacy and Safety Beyond Clinical Trials 01 - Articolo su rivista 2017 Cazzaniga M +
Efficacy and safety of vinorelbine-capecitabine oral metronomic combinaton in elderly metastatc breast cancer patents: VICTOR-1 study 01 - Articolo su rivista 2017 Cazzaniga MEBidoli P +
Mostrati risultati da 21 a 40 di 78
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile